Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $175.32 million. The enterprise value is $141.58 million.

Market Cap	175.32M
Enterprise Value	141.58M

Important Dates

The last earnings date was Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.56 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	6.56M
Shares Outstanding	6.56M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	9.11%
Owned by Institutions (%)	32.19%
Float	2.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.37
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 30.33, with a Debt / Equity ratio of 0.58.

Current Ratio	30.33
Quick Ratio	14.34
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.75

Financial Efficiency

Return on equity (ROE) is -44.50% and return on invested capital (ROIC) is -13.14%.

Return on Equity (ROE)	-44.50%
Return on Assets (ROA)	-12.59%
Return on Invested Capital (ROIC)	-13.14%
Return on Capital Employed (ROCE)	-23.79%
Revenue Per Employee	n/a
Profits Per Employee	-$5.57M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +143.96% in the last 52 weeks. The beta is 1.80, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	+143.96%
50-Day Moving Average	16.74
200-Day Moving Average	25.21
Relative Strength Index (RSI)	62.71
Average Volume (20 Days)	310,700

Short Selling Information

The latest short interest is 452,775, so 6.90% of the outstanding shares have been sold short.

Short Interest	452,775
Short Previous Month	561,952
Short % of Shares Out	6.90%
Short % of Float	17.09%
Short Ratio (days to cover)	2.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-54.76M
Pretax Income	-123.32M
Net Income	-78.03M
EBITDA	-51.64M
EBIT	-54.76M
Earnings Per Share (EPS)	-$11.97

Full Income Statement

Balance Sheet

The company has $103.65 million in cash and $84.28 million in debt, giving a net cash position of $19.38 million or $2.95 per share.

Cash & Cash Equivalents	103.65M
Total Debt	84.28M
Net Cash	19.38M
Net Cash Per Share	$2.95
Equity (Book Value)	144.91M
Book Value Per Share	22.09
Working Capital	212.04M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-45.50M
Capital Expenditures	n/a
Free Cash Flow	-45.50M
FCF Per Share	-$6.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.21%
Shareholder Yield	-0.21%
Earnings Yield	-48.48%
FCF Yield	-28.27%

Analyst Forecast

The average price target for Instil Bio is $119.00, which is 345.19% higher than the current price. The consensus rating is "Buy".

Price Target	$119.00
Price Target Difference	345.19%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2